{"id":"https://openalex.org/W4249732929","doi":"https://doi.org/10.1096/fasebj.20.4.a72-a","title":"RAS\u2010mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian epithelial cells","display_name":"RAS\u2010mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian epithelial cells","publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W4249732929","doi":"https://doi.org/10.1096/fasebj.20.4.a72-a"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.20.4.a72-a","doi":"https://doi.org/10.1096/fasebj.20.4.a72-a","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.20.4.a72-a","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064997314","display_name":"Fang C. Mei","orcid":"https://orcid.org/0000-0002-2589-1036","observed_orcids":["https://orcid.org/0000-0002-2589-1036"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fang Mei","raw_affiliation_strings":["Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd., Galveston, Texas, 77555-1031"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd., Galveston, Texas, 77555-1031","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041946191","display_name":"Travis W. Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Travis W. Young","raw_affiliation_strings":["Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd., Galveston, Texas, 77555-1031"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd., Galveston, Texas, 77555-1031","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080619609","display_name":"Xiaodong Cheng","orcid":"https://orcid.org/0000-0002-3479-1694","observed_orcids":["https://orcid.org/0000-0002-3479-1694"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaodong Cheng","raw_affiliation_strings":["Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd., Galveston, Texas, 77555-1031"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd., Galveston, Texas, 77555-1031","institution_ids":["https://openalex.org/I55302922"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I55302922"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.35886274,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"20","issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opcml","display_name":"OPCML","score":0.9879999756813049},{"id":"https://openalex.org/keywords/ras-signaling","display_name":"Ras signaling","score":0.8220000267028809},{"id":"https://openalex.org/keywords/epigenetic-silencing","display_name":"epigenetic silencing","score":0.8080000281333923},{"id":"https://openalex.org/keywords/promoter-hypermethylation","display_name":"promoter hypermethylation","score":0.972000002861023},{"id":"https://openalex.org/keywords/dna-methyltransferases","display_name":"DNA methyltransferases","score":0.5879999995231628},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.6320000290870667},{"id":"https://openalex.org/keywords/ovarian-epithelial-cells","display_name":"ovarian epithelial cells","score":0.6800000071525574},{"id":"https://openalex.org/keywords/oncogenic-transformation","display_name":"oncogenic transformation","score":0.9520000219345093},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.746999979019165},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.6561203002929688},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.647254228591919},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.6229110360145569},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6044317483901978},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5192775726318359},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4445617198944092},{"id":"https://openalex.org/C140173407","wikidata":"https://www.wikidata.org/wiki/Q1138358","display_name":"CpG site","level":5,"score":0.4141477942466736},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3909718990325928},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.36055171489715576},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22997722029685974},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20937415957450867},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12382715940475464}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.20.4.a72-a","doi":"https://doi.org/10.1096/fasebj.20.4.a72-a","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.20.4.a72-a","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2125131431","https://openalex.org/W2413606874","https://openalex.org/W2432996367","https://openalex.org/W2312903014","https://openalex.org/W2144797938","https://openalex.org/W2003673069","https://openalex.org/W2026631621","https://openalex.org/W2051670302","https://openalex.org/W2103485245","https://openalex.org/W2443070349"],"abstract_inverted_index":{"Opioid":[0],"binding":[1],"protein/cell":[2],"adhesion":[3],"molecule\u2010like":[4],"gene":[5,168],"(OPCML),":[6],"a":[7,66,85],"recently":[8],"identified":[9],"tumor\u2010suppressor":[10],"gene,":[11],"is":[12,45,157],"frequently":[13],"inactivated":[14],"by":[15,84,134],"allele":[16],"loss":[17,87],"and":[18,39,43,107,121,145,166],"CpG":[19],"island":[20],"promoter":[21,98,120,164],"methylation":[22],"in":[23,47,65,101,125,149,189,194],"epithelial":[24,105,196],"ovarian":[25,49,70,104,197],"cancer.":[26,198],"Since":[27],"elevated":[28],"activation":[29,178],"of":[30,37,41,56,63,88,117,130,147,170,179,192],"the":[31,53,60,96,110,118,143,161,180],"RAS":[32,42,58,77,132,155,181],"signaling":[33,182],"pathway,":[34],"including":[35],"overexpression":[36],"HER\u20102/neu":[38],"mutations":[40],"BRAF,":[44],"common":[46],"human":[48,69,103,195],"carcinoma,":[50],"we":[51],"examined":[52],"cellular":[54],"effect":[55],"oncogenic":[57,80,131,154],"on":[59],"expression":[61,124],"status":[62],"OPCML":[64,89,97,119,123,148,163,193],"genetically":[67],"defined":[68],"cancer":[71],"model.":[72],"Our":[73],"study":[74,175],"revealed":[75],"that":[76,95,153,177],"V12":[78,140],"\u2010mediated":[79],"transformation":[81],"was":[82,99],"accompanied":[83],"concomitant":[86],"expression.":[90],"Methylation\u2010sensitive":[91],"PCR":[92],"analysis":[93],"showed":[94],"hypermethylated":[100],"RAS\u2010transformed":[102],"cells,":[106,151],"treatment":[108],"with":[109],"DNA":[111],"methyltransferase":[112],"inhibitor,":[113],"5\u2032\u2010aza\u20102\u2032\u2010deoxycytidine":[114],"promoted":[115],"demethylation":[116,144],"restored":[122],"T29H":[126,150],"cells.":[127],"Furthermore,":[128],"suppression":[129],"activity":[133,156],"stable":[135],"siRNA":[136],"specific":[137],"for":[138,160],"HRAS":[139],"led":[141],"to":[142],"re\u2010expression":[146],"demonstrating":[152],"directly":[158],"responsible":[159],"observed":[162],"hypermethylation":[165],"epigenetic":[167,190],"silencing":[169],"OPCML.":[171],"Taken":[172],"together,":[173],"our":[174],"suggests":[176],"pathway":[183],"may":[184],"play":[185],"an":[186],"important":[187],"role":[188],"inactivation":[191]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-05-12T00:00:00"}